155 related articles for article (PubMed ID: 38599294)
1. The mechanism of covalent inhibition of LAR phosphatase by illudalic acid.
Hansen DT; Rueb NJ; Levinzon ND; Cheatham TE; Gaston R; Tanvir Ahmed K; Osburn-Staker S; Cox JE; Dudley GB; Barrios AM
Bioorg Med Chem Lett; 2024 May; 104():129740. PubMed ID: 38599294
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and PTP Inhibitory Activity of Illudalic Acid and Its Methyl Ether, with Insights into Selectivity for LAR PTP over Other Tyrosine Phosphatases under Physiologically Relevant Conditions.
McCullough BS; Batsomboon P; Hutchinson KB; Dudley GB; Barrios AM
J Nat Prod; 2019 Dec; 82(12):3386-3393. PubMed ID: 31809044
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and LAR inhibition of 7-alkoxy analogues of illudalic acid.
Ling Q; Zhou YY; Cai ZL; Zhang YH; Xiong B; Ma LP; Wang X; Li X; Li J; Shen JK
Yao Xue Xue Bao; 2010 Nov; 45(11):1385-97. PubMed ID: 21355526
[TBL] [Abstract][Full Text] [Related]
4. Illudalic acid as a potential LAR inhibitor: synthesis, SAR, and preliminary studies on the mechanism of action.
Ling Q; Huang Y; Zhou Y; Cai Z; Xiong B; Zhang Y; Ma L; Wang X; Li X; Li J; Shen J
Bioorg Med Chem; 2008 Aug; 16(15):7399-409. PubMed ID: 18579388
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of illudalic acid and analogous phosphatase inhibitors.
Fulo HF; Rueb NJ; Gaston R; Batsomboon P; Ahmed KT; Barrios AM; Dudley GB
Org Biomol Chem; 2021 Dec; 19(48):10596-10600. PubMed ID: 34847212
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development.
Henderson IM; Zeng F; Bhuiyan NH; Luo D; Martinez M; Smoake J; Bi F; Perera C; Johnson D; Prisinzano TE; Wang W; Uhl GR
Biochem Pharmacol; 2022 Jan; 195():114868. PubMed ID: 34863978
[TBL] [Abstract][Full Text] [Related]
7. Derivatives of the Fungal Natural Product Illudalic Acid Inhibit the Activity of Protein Histidine Phosphatase PHPT1.
Wang H; Gaston R; Ahmed KT; Dudley GB; Barrios AM
ChemMedChem; 2023 Aug; 18(15):e202300187. PubMed ID: 37267298
[TBL] [Abstract][Full Text] [Related]
8. Simplified receptor based pharmacophore approach to retrieve potent PTP-LAR inhibitors using apoenzyme.
Ajay D; Sobhia ME
Curr Comput Aided Drug Des; 2011 Sep; 7(3):159-72. PubMed ID: 21726194
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Platelet Derived Growth Factor Signaling by Leukocyte Common Antigen-related (LAR) Protein Tyrosine Phosphatase: A Quantitative Phosphoproteomics Study.
Sarhan AR; Patel TR; Creese AJ; Tomlinson MG; Hellberg C; Heath JK; Hotchin NA; Cunningham DL
Mol Cell Proteomics; 2016 Jun; 15(6):1823-36. PubMed ID: 27074791
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel, less toxic PTP-LAR inhibitors using in silico strategies: pharmacophore modeling, SADMET-based virtual screening and docking.
Ajay D; Sobhia ME
J Mol Model; 2012 Jan; 18(1):187-201. PubMed ID: 21523550
[TBL] [Abstract][Full Text] [Related]
11. Redox regulation of dimerization of the receptor protein-tyrosine phosphatases RPTPalpha, LAR, RPTPmu and CD45.
Groen A; Overvoorde J; van der Wijk T; den Hertog J
FEBS J; 2008 May; 275(10):2597-604. PubMed ID: 18422654
[TBL] [Abstract][Full Text] [Related]
12. The leukocyte common antigen-related protein LAR: candidate PTP for inhibitory targeting.
Mooney RA; LeVea CM
Curr Top Med Chem; 2003; 3(7):809-19. PubMed ID: 12678846
[TBL] [Abstract][Full Text] [Related]
13. Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor.
Tsujikawa K; Kawakami N; Uchino Y; Ichijo T; Furukawa T; Saito H; Yamamoto H
Mol Endocrinol; 2001 Feb; 15(2):271-80. PubMed ID: 11158333
[TBL] [Abstract][Full Text] [Related]
14. The LAR protein tyrosine phosphatase enables PDGF β-receptor activation through attenuation of the c-Abl kinase activity.
Zheng W; Lennartsson J; Hendriks W; Heldin CH; Hellberg C
Cell Signal; 2011 Jun; 23(6):1050-6. PubMed ID: 21300149
[TBL] [Abstract][Full Text] [Related]
15. The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.
Wallace MJ; Fladd C; Batt J; Rotin D
Mol Cell Biol; 1998 May; 18(5):2608-16. PubMed ID: 9566880
[TBL] [Abstract][Full Text] [Related]
16. LAR protein tyrosine phosphatase receptor associates with TrkB and modulates neurotrophic signaling pathways.
Yang T; Massa SM; Longo FM
J Neurobiol; 2006 Nov; 66(13):1420-36. PubMed ID: 17013927
[TBL] [Abstract][Full Text] [Related]
17. Protein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase function.
Xie Y; Massa SM; Ensslen-Craig SE; Major DL; Yang T; Tisi MA; Derevyanny VD; Runge WO; Mehta BP; Moore LA; Brady-Kalnay SM; Longo FM
J Biol Chem; 2006 Jun; 281(24):16482-92. PubMed ID: 16613844
[TBL] [Abstract][Full Text] [Related]
18. Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.
Uhl GR; Martinez MJ; Paik P; Sulima A; Bi GH; Iyer MR; Gardner E; Rice KC; Xi ZX
Proc Natl Acad Sci U S A; 2018 Nov; 115(45):11597-11602. PubMed ID: 30348770
[TBL] [Abstract][Full Text] [Related]
19. LAR tyrosine phosphatase receptor: alternative splicing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats.
Zhang JS; Longo FM
J Cell Biol; 1995 Feb; 128(3):415-31. PubMed ID: 7844155
[TBL] [Abstract][Full Text] [Related]
20. LAR tyrosine phosphatase receptor: proximal membrane alternative splicing is coordinated with regional expression and intraneuronal localization.
Honkaniemi J; Zhang JS; Yang T; Zhang C; Tisi MA; Longo FM
Brain Res Mol Brain Res; 1998 Sep; 60(1):1-12. PubMed ID: 9748473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
